Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 BRL | +4.12% | -5.23% | -7.92% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.5 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.92% | 196M | - | ||
+2.56% | 101B | A- | ||
-1.20% | 65.99B | A- | ||
+47.62% | 41.98B | B | ||
+15.99% | 38.65B | B | ||
+4.25% | 32.16B | A- | ||
+8.78% | 19.21B | B- | ||
+12.32% | 16.76B | C+ | ||
+17.69% | 15.07B | B- | ||
+8.31% | 14.82B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DEXP3 Stock
- Ratings Dexxos Participações S.A.